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The aim of this paper is to describe a case report of EMP in an HIV-positive patient. A 44-year-old, dark-skinned HIV-infected
woman was referred to the Oral Diseases Treatment Center with a swelling at palate and left gingival fornix in the maxilla. Biopsy
was taken and the oral lesion was diagnosed as EMP with well-differentiated plasma cells and restriction of the lambda light-
chain. Skeletal survey was performed and no radiograph alterations were observed, thus supporting the diagnosis of EMP. Patient
was referred to treatment and after two months of chemo and radiotherapy, an expanding lesion was observed in L5/S1 patient’s
vertebrae. Biopsy of the spinal lesion was consistent with lymphoma with plasmocitary differentiation, supporting the diagnosis of
multiple myeloma (MM). Regarding the medical history, the final diagnostic was an oral extramedullary plasmacytoma with rapid
progression into multiple myeloma. It is crucial to emphasize the relevance of HIV infection as a risk factor for both aggressive
clinical behavior and unusual clinical presentation of extramedullary plasmacytoma cases.
1. Introduction
According to the World Health Organization (WHO), extra-
medullary plasmacytoma (EMP) is a monoclonal plasmatic
soft-tissue proliferation, without bone marrow involvement.
It is a tumor composed almost exclusively of plasma cells
arranged in clusters or sheets with a scant, delicate, support-
ive, and connective tissue stroma [1, 2].
Extramedullary plasma cell tumors occur in a wide vari-
ety of organs and tissues. However, it has been reported in
head and neck of more than 80% of the cases, usually in the
nasal cavity with associated bone destruction [3, 4]. Extra-
medullary plasmacytomas vary considerably in size, the
diameter ranging from one to several centimeters. They are
usually well limited, firm, and spherical, but they may be
lobulated, pedunculated, or polypoid and show evidence of
infiltration. The great majority are yellow-gray with a red
cut surface, while some of the other tumors have a blue-red
appearance. Involved regional lymph nodes are firm, gray
white, and may measure up to 3 cm.The symptoms are those
due to pressure and obstruction [5]. The tumor is usually
highly sensitive to radiotherapy, and most cases do not
progress into multiple myeloma [3, 6]. Recently, Ngolet et al.
[7] reported that a secondary metastatic cutaneous plasma-
cytoma is a multiple extramedullary plasma cell proliferation
involving skin. Its occurrence was associated with advanced
myeloma and a poor prognosis.
Over the last 10 years, it has become apparent that the
spectrum ofmalignant diseases associated with human imm-
unodeficiency virus (HIV) has been expanding [8]. Plasma
cell tumors are extremely rare in this group of patients [9]
and it has been found that these patients are younger and they
present a greater tendency to develop solitary extramedullary
plasmacytoma with atypical clinical evolution and greater
aggressiveness of the neoplastic process [10]. It has a shorter
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Figure 1: Clinical intraoral presentation at time of the first appoint-
ment.
latency period and often has extramedullary involvement
with unusual clinical presentation [11–13]. There are only few
cases of extramedullary plasmacytoma of the head and neck
region associated with HIV-positive patients published in the
literature. Therefore, the aim of this paper is to present case
report of an HIV-positive patient diagnosed for extramedul-
lary plasmacytoma.
2. Case Report
A 44-year-old, dark-skinned woman was referred to the Oral
Disease Treatment Center of Sa˜o Leopoldo Mandic Dental
School, Campinas/Brazil, with a complaint of difficulty in
wearing her dentures. Her medical history revealed HIV
infection, with irregular use of antiretroviral therapy. Patient
also reported multiple sexual partners and use of injection
drugs, cocaine, crack, and marijuana.
Clinical examination revealed an asymptomatic swelling
at right gingival sulcus in the maxilla (Figure 1).
Computed tomography scan revealed a solid tumor mass
on the floor of the nasal cavity, measuring 5.6 × 5.2 × 5.2 cm,
leading to erosion of the hard palate and of the medial wall of
the maxillary sinus, bilaterally (Figure 2). No involvement of
cervical lymph nodes was present.
Diagnostic hypotheses were lymphoma, osteosarcoma,
and malignant salivary gland neoplasia. Fine needle aspira-
tion and incisional biopsy were performed at the same day
of the initial appointment. Microscopic analysis revealed a
neoplasm of well-differentiated plasma cells, with restriction
of the lambda light-chain (Figure 3). Immunohistochemistry
(IHC) showed positivity for CD138 and EMA in the neo-
plasm; CD79a in a strong and diffuse pattern through the
neoplasm; CD56 in the membrane; and lambda in a focal
pattern in the neoplasm. IHC was negative for kappa, IgG,
and IgM. Bone marrow biopsy revealed reactional lympho-
plasmacytic infiltrate and absence of infiltrative neoplastic
cells. IHC showed positivity for CD20, CD3, kappa, and
lambda (Figure 3).
In addition, total serum proteins, albumin-globulin ratio,
and all other laboratory tests were within normal limits.
No Bence Jones protein was found. Skeletal survey was
performed, with no alterations on plain radiographs. These
findings, in association with clinical data, led to the definitive
diagnosis of EMP.
After the diagnosis procedure, the tumor was classified as
T4N0M0 (Figure 4) and the patient was submitted to chemo-
therapy with thalidomide, dexamethasone, and pamidronate.
The tumor was also treated by radiation a total dosage of
42Gy and a fraction size of 200 cGy during 2 months. When
examined 3 months later, the nasal obstruction was relieved
completely and no residual tumor was observed (Figure 5).
However, two months later, the patient developed sen-
sitive and motor numbness in the lower limbs. Magnetic
resonance imaging showed an expanding lesion in L5/S1
vertebrae, presenting medulla compression. Biopsy of the
spinal lesion was performed, and microscopic features were
consistent with lymphoma with plasmocitary differentiation.
IHC was positive for CD20, CD3, and lambda and negative
for kappa.
According to World Health Organization Classification
of Tumors [1], the diagnosis of a plasmacytoma on biopsy
and the presence of lytic bone lesions showmultiplemyeloma
diagnosis (MM).The patient was submitted to chemotherapy
with rituximab, cyclophosphamide, doxorubicin, vincristine,
and prednisolone but discontinued treatment and quit
attending the medical appointments. Information was later
obtained that the patient had deceased for unknown causes,
probably due to complications of the untreated multiple
myeloma.
3. Discussion
The present study reports a case of EMP with atypical
features which have been associated with the presence of HIV
infection. Such neoplasms in this group of patients are extre-
mely rare [9]. In addition, this tumor shows a different clini-
cal behavior among HIV patients: occurrence in a younger
age group, with a shorter latency period, with often extra-
medullary involvement and in a more aggressive clinical
course, with a poor prognosis due to the poor immunity of the
patient [9, 11–14]. Indeed, the mean of age of EMP is 60 years
in noninfected patients [2], but in HIV-positive patients the
mean age is 33 years [15]. In this study, the patient was 44
years-old.
Although a male predominance has been reported for
EMP [5], in this study the patient was female. Other char-
acteristics of the case herein reported are consistent with the
ones described in the literature. Monoclonal gammopathies
have a higher incidence among dark-skinned individuals, and
EMP has been reported to occur more frequently in nasal
cavity, nasopharyngeal, and paranasal sinus [1, 3, 16, 17]. In
this study, the patient was dark skinned, and it is likely that
the lesion was originated from the nasal cavity. However, the
size of the lesion (bigger than 5 cm), at the time of diagnosis,
makes it difficult to define a precise location.
According to Joseph et al. [10], differentiating between
plasmablastic lymphoma, plasma cell myeloma, and the
solitary EMPs is in itself a diagnostic challenge. EMPhas been
treated with surgical excision, radiotherapy, chemotherapy,
or combined surgery and radiotherapy [9]. EMP is a highly
radiosensitive lesion; however, no firmly dose-response rela-
tionship has been established due to small patient series
and low local failure rates [6]. An optimal radiation dosage
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Figure 2: Extent of bone destruction seen on CT scans ((a) CT, axial view; (b) CT, coronal view).
Figure 3: Microscopic examination revealed a plasma cell tumor. The histological sections showed lymphoid origin of tumor fragment
characterized by the proliferation of atypical plasma cells which are arranged in sheets (a, HE); immunohistochemical reactions were positive
for plasm cell (b); negative for kappa (c); and positive for lambda (d).
appears to be in the range of 40–50Gy [18]. In the present
case, a complete regression of the EMP was obtained follow-
ing a total dosage of 42Gy of radiotherapy.
The case presented in this study showed a rapid evolution
into MM, only 6 months after the initial diagnosis, in an
aggressive clinical behavior. It is estimated that 20% to 36% of
the cases of EMP can progress intoMM [1, 3, 4, 17]. However,
in HIV-positive patients, plasma cell tumors may present at
unusual sites and progress rapidly to involve multiple sites,
including the soft tissues and viscera [19].
Previous studies have investigated the risk factors that
would predispose patients with solitary plasmacytoma to dis-
ease progression.Thus, in age below 60 years, extramedullary
localization and radiotherapy have been related to a 10-year
disease-free survival [4]. On the other hand, unfavorable
factors for MM development were identified on people older
than 60 years and bone localization [4].
The case reported here presented all factors for a favorable
outcome and even so showed an aggressive evolution of EMP
intoMMand eventually death. Such outcome emphasizes the
relevance of HIV infection in a more aggressive clinical cause
and, eventually, a poor prognosis in patients with EMP [8, 11,
19].
The proposed mechanism for this clinical behavior in
HIV-positive patients is related to impaired T-cell function,
deregulation, and hyperactivity of B cells.These factors, asso-
ciated with persistent antigenic stimulation, could encourage
transformation of stimulated B cells into malignant plasma
cells [15]. However, the final outcome of the case herein
reported cannot be adequately discussed since the patient
discontinued her treatment after the diagnosis of MM. So far
there have been no large studies reporting an optimal therapy
for myeloma and other plasma cell dyscrasias in the HIV-
positive population [14].
4 Case Reports in Dentistry
Figure 4: Clinical presentation at time of tumor staging ((a) fontal view; (b) coronal view; (c) intraoral view).
Figure 5: Clinical intraoral presentation after two months of
chemo-radiotherapy treatment.
Concerning themicroscopic features, theWHOdiagnos-
tic criteria state that EMP shows identical microscopic and
immunophenotype features as those of plasma cell myeloma
[1]. Microscopic features frequently show plasma cells mor-
phology, and IHCmay show expression of EMA, an epithelial
membrane antigen of plasma cells; of CD56/58, a natural
killer antigen; of the immunoglobulin-associated antigen
CD79a; and of CD138, a reliable marker for identifying and
quantifying normal and tumoral plasma cells in paraffin sec-
tions [1, 19]. Light-chain immunoglobulins are identified in
11% of the cases of plasma cell tumors, with a higher pre-
valence of the kappa light-chain [20]. In the case reported
here, unusualmicroscopic features were observed, with a pre-
dominance of lambda light-chain among monoclonal gam-
mopathies.
Regarding previous studies there is emphasis on the
association of HIV infection, EMP, and MM. Ngolet et al. [7]
described a secondarymetastatic cutaneous plasmacytoma as
a multiple extramedullary plasma cell proliferation involving
skin. Its occurrence was associated with advanced myeloma.
According to Hazarika et al. [21], in view of high incidence
of progression to MM in due course the patients should be
kept under constant surveillance. However, further studies
are required to identify risk factors that correlate EMP and
its rapid progression into MM.
4. Conclusion
In conclusion, this study reports a case of EMP in an HIV-
positive patient. It is important to observe the association
of HIV infection and a higher incidence of these lesions, as
well as its aggressive clinical behavior and unusual clinical
presentation.
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